What each role should evaluate
An owner should evaluate Promise on wholesale pricing and white-label fit. Because rates flow through a dedicated account manager rather than a self-serve catalog, the owner should confirm per-vial cost on top GLP-1 and hormone SKUs, volume discount thresholds, and white-label minimums if patient branding matters. An operations lead should evaluate portal workflow: submission paths (portal, eRx, LifeFile, API), fulfillment turnaround, COA access, and direct-to-patient tracking in 42 licensed states.
A prescriber should evaluate clinical accuracy: available semaglutide and tirzepatide concentrations, custom formulation support, and whether patient-specific 503A rules are met on every order. Each role's risk is different, but they share one dependency — whether one compounder portal covers the whole refill day or whether the clinic also routes SKUs through other 503A partners that Promise cannot fulfill in the same session.